Invention Grant
- Patent Title: Methods for antagonizing a melanocortin 4 receptor
-
Application No.: US18162052Application Date: 2023-01-31
-
Publication No.: US12187727B2Publication Date: 2025-01-07
- Inventor: Christopher Ryan Butler , Michelle Renee Garnsey , Kevin Alexander Ogilvie , Jana Polivkova , Matthew Forrest Sammons , Aaron Christopher Smith , Qingyi Yang
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Jessica Zimberlin Eastman
- Main IPC: A61K31/438
- IPC: A61K31/438 ; A61P1/08 ; A61P3/04 ; A61P19/00 ; A61P21/00 ; A61P29/00 ; C07D471/20 ; C07D519/00
Abstract:
Described herein are methods of treating MC4R-related conditions, diseases, or disorders by administering compounds of Formula I: or their pharmaceutically acceptable salts, wherein R1, R2, R3, X1, Y1, Y2, Y3, Y4 and Y5 are defined herein. Such conditions, diseases, or disorders include cachexia, anorexia, or anorexia nervosa.
Public/Granted literature
- US20230174532A1 METHODS FOR ANTAGONIZING A MELANOCORTIN 4 RECEPTOR Public/Granted day:2023-06-08
Information query
